Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank Disease ID
1 Complement and coagulation cascades 💬
[1] F2 💬 Dabigatran 💬 Dabigatran [5] 51, 75, 85, 91, 124 💬
2 Complement and coagulation cascades 💬
[1] F2 💬 Dabigatran etexilate mesylate 💬 Dabigatran etexilate [2] 51, 75 💬
3 Complement and coagulation cascades 💬
[1] F2 💬 Dabigatran etexilate 💬 Dabigatran etexilate [2] 51, 75 💬
4 Complement and coagulation cascades 💬
[1] F2 💬 Thrombomodulin alfa 💬 Thrombomodulin Alfa [1] 85 💬
5 Coronavirus disease - COVID-19 💬
[1] F2 💬 Dabigatran 💬 Dabigatran [5] 51, 75, 85, 91, 124 💬
6 Coronavirus disease - COVID-19 💬
[1] F2 💬 Dabigatran etexilate mesylate 💬 Dabigatran etexilate [2] 51, 75 💬
7 Coronavirus disease - COVID-19 💬
[1] F2 💬 Dabigatran etexilate 💬 Dabigatran etexilate [2] 51, 75 💬
8 Coronavirus disease - COVID-19 💬
[1] F2 💬 Thrombomodulin alfa 💬 Thrombomodulin Alfa [1] 85 💬
9 Neuroactive ligand-receptor interaction 💬
[1] F2 💬 Dabigatran 💬 Dabigatran [5] 51, 75, 85, 91, 124 💬
10 Neuroactive ligand-receptor interaction 💬
[1] F2 💬 Dabigatran etexilate mesylate 💬 Dabigatran etexilate [2] 51, 75 💬
11 Neuroactive ligand-receptor interaction 💬
[1] F2 💬 Dabigatran etexilate 💬 Dabigatran etexilate [2] 51, 75 💬
12 Neuroactive ligand-receptor interaction 💬
[1] F2 💬 Thrombomodulin alfa 💬 Thrombomodulin Alfa [1] 85 💬
13 Pathogenic Escherichia coli infection 💬
[1] F2 💬 Dabigatran 💬 Dabigatran [5] 51, 75, 85, 91, 124 💬
14 Pathogenic Escherichia coli infection 💬
[1] F2 💬 Dabigatran etexilate mesylate 💬 Dabigatran etexilate [2] 51, 75 💬
15 Pathogenic Escherichia coli infection 💬
[1] F2 💬 Dabigatran etexilate 💬 Dabigatran etexilate [2] 51, 75 💬
16 Pathogenic Escherichia coli infection 💬
[1] F2 💬 Thrombomodulin alfa 💬 Thrombomodulin Alfa [1] 85 💬
17 Pathways in cancer 💬
[1] F2 💬 Dabigatran 💬 Dabigatran [5] 51, 75, 85, 91, 124 💬
18 Pathways in cancer 💬
[1] F2 💬 Dabigatran etexilate mesylate 💬 Dabigatran etexilate [2] 51, 75 💬
19 Pathways in cancer 💬
[1] F2 💬 Dabigatran etexilate 💬 Dabigatran etexilate [2] 51, 75 💬
20 Pathways in cancer 💬
[1] F2 💬 Thrombomodulin alfa 💬 Thrombomodulin Alfa [1] 85 💬
21 Phospholipase D signaling pathway 💬
[1] F2 💬 Dabigatran 💬 Dabigatran [5] 51, 75, 85, 91, 124 💬
22 Phospholipase D signaling pathway 💬
[1] F2 💬 Dabigatran etexilate mesylate 💬 Dabigatran etexilate [2] 51, 75 💬
23 Phospholipase D signaling pathway 💬
[1] F2 💬 Dabigatran etexilate 💬 Dabigatran etexilate [2] 51, 75 💬
24 Phospholipase D signaling pathway 💬
[1] F2 💬 Thrombomodulin alfa 💬 Thrombomodulin Alfa [1] 85 💬
25 Platelet activation 💬
[1] F2 💬 Dabigatran 💬 Dabigatran [5] 51, 75, 85, 91, 124 💬
26 Platelet activation 💬
[1] F2 💬 Dabigatran etexilate mesylate 💬 Dabigatran etexilate [2] 51, 75 💬
27 Platelet activation 💬
[1] F2 💬 Dabigatran etexilate 💬 Dabigatran etexilate [2] 51, 75 💬
28 Platelet activation 💬
[1] F2 💬 Thrombomodulin alfa 💬 Thrombomodulin Alfa [1] 85 💬
29 Regulation of actin cytoskeleton 💬
[1] F2 💬 Dabigatran 💬 Dabigatran [5] 51, 75, 85, 91, 124 💬
30 Regulation of actin cytoskeleton 💬
[1] F2 💬 Dabigatran etexilate mesylate 💬 Dabigatran etexilate [2] 51, 75 💬
31 Regulation of actin cytoskeleton 💬
[1] F2 💬 Dabigatran etexilate 💬 Dabigatran etexilate [2] 51, 75 💬
32 Regulation of actin cytoskeleton 💬
[1] F2 💬 Thrombomodulin alfa 💬 Thrombomodulin Alfa [1] 85 💬